These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 19231760)
41. Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors". Onuigbo MA; Agbasi N World J Nephrol; 2014 Aug; 3(3):31-49. PubMed ID: 25332895 [TBL] [Abstract][Full Text] [Related]
42. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease]. Ravera M; Paoletti E Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148 [TBL] [Abstract][Full Text] [Related]
43. A new initiative in nephrology: 'Kidney disease: improving global outcomes'. Lameire N; Eknoyan G; Barsoum R; Eckardt KU; Levin A; Levin N; Locatelli F; MacLeod A; Vanholder R; Walker R; Wang H Contrib Nephrol; 2005; 149():90-99. PubMed ID: 15876832 [TBL] [Abstract][Full Text] [Related]
44. A quick guide to evidence-based chronic kidney disease care for the primary care physician. Fox CH; Voleti V; Khan LS; Murray B; Vassalotti J Postgrad Med; 2008 Jul; 120(2):E01-6. PubMed ID: 18654062 [TBL] [Abstract][Full Text] [Related]
45. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Coresh J; Astor BC; Greene T; Eknoyan G; Levey AS Am J Kidney Dis; 2003 Jan; 41(1):1-12. PubMed ID: 12500213 [TBL] [Abstract][Full Text] [Related]
46. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Mammen C; Al Abbas A; Skippen P; Nadel H; Levine D; Collet JP; Matsell DG Am J Kidney Dis; 2012 Apr; 59(4):523-30. PubMed ID: 22206744 [TBL] [Abstract][Full Text] [Related]
47. Use of Renin-Angiotensin System Blockade in Advanced CKD: An NKF-KDOQI Controversies Report. Weir MR; Lakkis JI; Jaar B; Rocco MV; Choi MJ; Kramer HJ; Ku E Am J Kidney Dis; 2018 Dec; 72(6):873-884. PubMed ID: 30201547 [TBL] [Abstract][Full Text] [Related]
48. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. McClellan WM; Langston RD; Presley R J Am Soc Nephrol; 2004 Jul; 15(7):1912-9. PubMed ID: 15213281 [TBL] [Abstract][Full Text] [Related]
49. Predictors of new-onset decline in kidney function in a general middle-european population. Obermayr RP; Temml C; Knechtelsdorfer M; Gutjahr G; Kletzmayr J; Heiss S; Ponholzer A; Madersbacher S; Oberbauer R; Klauser-Braun R Nephrol Dial Transplant; 2008 Apr; 23(4):1265-73. PubMed ID: 18039642 [TBL] [Abstract][Full Text] [Related]
50. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651 [TBL] [Abstract][Full Text] [Related]
51. Clinical practice guidelines in nephrology: evaluation, classification, and stratification of chronic kidney disease. Bailie GR; Uhlig K; Levey AS Pharmacotherapy; 2005 Apr; 25(4):491-502. PubMed ID: 15977910 [TBL] [Abstract][Full Text] [Related]
52. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease. Moinuddin I; Leehey DJ Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113 [TBL] [Abstract][Full Text] [Related]
53. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design. Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136 [TBL] [Abstract][Full Text] [Related]
54. Monitoring renal function: measured and estimated glomerular filtration rates - a review. Salgado JV; Neves FA; Bastos MG; França AK; Brito DJ; Santos EM; Salgado Filho N Braz J Med Biol Res; 2010 Jun; 43(6):528-36. PubMed ID: 20464341 [TBL] [Abstract][Full Text] [Related]
55. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. Cerasola G; Nardi E; Palermo A; Mulè G; Cottone S J Nephrol; 2011; 24(1):1-10. PubMed ID: 20437402 [TBL] [Abstract][Full Text] [Related]
56. Rate of change in kidney function and the risk of death: the case for incorporating the rate of kidney function decline into the CKD staging system. Al-Aly Z; Cepeda O Nephron Clin Pract; 2011; 119(2):c179-85; discussion c186. PubMed ID: 21811079 [TBL] [Abstract][Full Text] [Related]
57. Cost implications of caring for chronic kidney disease: are interventions cost-effective? Trivedi H Adv Chronic Kidney Dis; 2010 May; 17(3):265-70. PubMed ID: 20439095 [TBL] [Abstract][Full Text] [Related]
58. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. David S; Kümpers P; Lukasz A; Fliser D; Martens-Lobenhoffer J; Bode-Böger SM; Kliem V; Haller H; Kielstein JT Nephrol Dial Transplant; 2010 Aug; 25(8):2571-6. PubMed ID: 20179005 [TBL] [Abstract][Full Text] [Related]
59. Screening for, monitoring, and treatment of chronic kidney disease stages 1 to 3: a systematic review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Fink HA; Ishani A; Taylor BC; Greer NL; MacDonald R; Rossini D; Sadiq S; Lankireddy S; Kane RL; Wilt TJ Ann Intern Med; 2012 Apr; 156(8):570-81. PubMed ID: 22508734 [TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of carvedilol in treatment of heart failure with chronic kidney disease: a meta-analysis of randomized trials. Wali RK; Iyengar M; Beck GJ; Chartyan DM; Chonchol M; Lukas MA; Cooper C; Himmelfarb J; Weir MR; Berl T; Henrich WL; Cheung AK Circ Heart Fail; 2011 Jan; 4(1):18-26. PubMed ID: 21036889 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]